- Redesign Health is a global venture and applied technology firm that has launched over 60 healthcare companies since 2018, impacting more than 15 million patients and raising over $1.5 billion in funding.
- In December 2024, Redesign Health closed a $175 million investment fund aimed at scaling healthcare venture building and supporting founders committed to transforming the industry.
- Recently, Redesign Health backed the launch of Starfire, a commercial intelligence platform for life sciences, designed to help pharmaceutical companies automate analyses and enhance commercialization strategies.
- The ideal buyer for Redesign Health's solutions includes healthcare founders and pharmaceutical companies looking to navigate complex regulations and improve clinical and financial performance through innovative technology.
Consulting is the largest department with roughly one-third of the total staff (123 employees), underscoring the firm’s emphasis on advising and incubating new ventures. Business Management follows with 82 employees, providing operational guidance to portfolio companies. Marketing & Product (38) and Engineering (28) teams supply the creative and technical expertise needed to launch scalable solutions, while Banking & Wealth Management, Finance & Administration, Human Resources, Sales & Support, and Operations collectively account for the remainder. The spread of talent across these functions illustrates a broad, multidisciplinary approach to company building.
Redesign Health maintains a distributed footprint anchored in New York City, which hosts 112 employees and represents nearly one-third of the workforce. Another 154 employees work remotely or in unspecified locations, highlighting the company’s flexible work model. Smaller hubs are located in San Francisco (39), Boston (21), Chicago (17), Seattle (13), Atlanta (9), Philadelphia (10), Miami (3), and Austin (6), giving the organization a presence in several key U.S. innovation markets.
